Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab in NSTEMI
NCT01491074Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Aug 2011
- Primary completion
- Nov 2013
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in non-ST-elevation myocardial infarction (NSTEMI), sponsored by Oslo University Hospital. Started Aug 2011; status: completed.
02
Drugs
tocilizumab
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT01491074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01491074.